Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Know What’s Really Going On
...
Register
Focus Medical Necessity Efforts on Three Core Elements
...
Register
News at a Glance – Feb 2016
...
Register
Long-Awaited Final Rule Clarifies 60-day Repayment Deadline
From - G2 Compliance Advisor
Labs and other providers are required by a provision enacted in the Affordable Care Act to return to Medicare overpayments within 60 days of…
Walgreens Tells Theranos to Fix Problems or Lose Pact
From - Laboratory Industry Report
Walgreens has told Theranos to get its act together, or get out…
PSA Testing Patterns Vary By Medical Specialty
From - Diagnostic Testing & Emerging Technologies
Prostate specific antigen (PSA) testing varies significantly by physician specialty, according to a research letter published online Feb. 8 in…
Shire and ACMG Partner to Support Medical Geneticist Training
From - National Intelligence Report
"As a result of advances in the area of genetic and genomic research and diagnostic testing, it is anticipated that the need for…
New Molecular Test for Cystic Fibrosis Promises Faster, Better, Cheaper Analysis
From - Diagnostic Testing & Emerging Technologies
The future of cystic fibrosis (CF) diagnosis is in sight. Testing for the genetic disease helped to fuel the first wave of clinical molecular diagnostics, and now an assay developed by…
2015 Had Promising Signs Amid Tough Fundraising Climate for Dx Cos
...
Register
Testing Trends to Watch for in 2016
...
Register